0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artificial Blood Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-19L4050
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artificial Blood Market Insights and Forecast to 2028
BUY CHAPTERS

Global Artificial Blood Market Research Report 2023

Code: QYRE-Auto-19L4050
Report
February 2023
Pages:89
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Artificial Blood Market

Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.
The global Artificial Blood market was valued at US$ 3505 million in 2022 and is anticipated to reach US$ 6771.3 million by 2029, witnessing a CAGR of 11.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artificial Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood.
The Artificial Blood market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Blood market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Dextro-Sang Corporation
  • BioPure Corporation
  • Sangart
  • Northfield Laboratories
  • Baxter International
  • Dentritech
  • FluorO2 Therapeutics
  • Nuvox Pharma
  • Alpha Therapeutic Corporation
  • HemoBioTech

Segment by Type

  • Human Blood
  • Synthetic Blood
  • Animal Blood

Segment by Application

  • Hemoglobin-Based Oxygen Carriers (HBOCs)
  • Perflurocarbon Emulsions (PFCEs)

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Artificial Blood companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Artificial Blood Market Report

Report MetricDetails
Report NameGlobal Artificial Blood Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Blood Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Human Blood
1.2.3 Synthetic Blood
1.2.4 Animal Blood
1.3 Market by Application
1.3.1 Global Artificial Blood Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Blood Market Perspective (2018-2029)
2.2 Artificial Blood Growth Trends by Region
2.2.1 Global Artificial Blood Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Blood Historic Market Size by Region (2018-2023)
2.2.3 Artificial Blood Forecasted Market Size by Region (2024-2029)
2.3 Artificial Blood Market Dynamics
2.3.1 Artificial Blood Industry Trends
2.3.2 Artificial Blood Market Drivers
2.3.3 Artificial Blood Market Challenges
2.3.4 Artificial Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Blood Players by Revenue
3.1.1 Global Top Artificial Blood Players by Revenue (2018-2023)
3.1.2 Global Artificial Blood Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Blood Revenue
3.4 Global Artificial Blood Market Concentration Ratio
3.4.1 Global Artificial Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Revenue in 2022
3.5 Artificial Blood Key Players Head office and Area Served
3.6 Key Players Artificial Blood Product Solution and Service
3.7 Date of Enter into Artificial Blood Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Blood Breakdown Data by Type
4.1 Global Artificial Blood Historic Market Size by Type (2018-2023)
4.2 Global Artificial Blood Forecasted Market Size by Type (2024-2029)
5 Artificial Blood Breakdown Data by Application
5.1 Global Artificial Blood Historic Market Size by Application (2018-2023)
5.2 Global Artificial Blood Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Blood Market Size (2018-2029)
6.2 North America Artificial Blood Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Blood Market Size by Country (2018-2023)
6.4 North America Artificial Blood Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Blood Market Size (2018-2029)
7.2 Europe Artificial Blood Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Blood Market Size by Country (2018-2023)
7.4 Europe Artificial Blood Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Market Size (2018-2029)
8.2 Asia-Pacific Artificial Blood Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Blood Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Blood Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Blood Market Size (2018-2029)
9.2 Latin America Artificial Blood Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Blood Market Size by Country (2018-2023)
9.4 Latin America Artificial Blood Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Market Size (2018-2029)
10.2 Middle East & Africa Artificial Blood Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Blood Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Blood Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dextro-Sang Corporation
11.1.1 Dextro-Sang Corporation Company Detail
11.1.2 Dextro-Sang Corporation Business Overview
11.1.3 Dextro-Sang Corporation Artificial Blood Introduction
11.1.4 Dextro-Sang Corporation Revenue in Artificial Blood Business (2018-2023)
11.1.5 Dextro-Sang Corporation Recent Development
11.2 BioPure Corporation
11.2.1 BioPure Corporation Company Detail
11.2.2 BioPure Corporation Business Overview
11.2.3 BioPure Corporation Artificial Blood Introduction
11.2.4 BioPure Corporation Revenue in Artificial Blood Business (2018-2023)
11.2.5 BioPure Corporation Recent Development
11.3 Sangart
11.3.1 Sangart Company Detail
11.3.2 Sangart Business Overview
11.3.3 Sangart Artificial Blood Introduction
11.3.4 Sangart Revenue in Artificial Blood Business (2018-2023)
11.3.5 Sangart Recent Development
11.4 Northfield Laboratories
11.4.1 Northfield Laboratories Company Detail
11.4.2 Northfield Laboratories Business Overview
11.4.3 Northfield Laboratories Artificial Blood Introduction
11.4.4 Northfield Laboratories Revenue in Artificial Blood Business (2018-2023)
11.4.5 Northfield Laboratories Recent Development
11.5 Baxter International
11.5.1 Baxter International Company Detail
11.5.2 Baxter International Business Overview
11.5.3 Baxter International Artificial Blood Introduction
11.5.4 Baxter International Revenue in Artificial Blood Business (2018-2023)
11.5.5 Baxter International Recent Development
11.6 Dentritech
11.6.1 Dentritech Company Detail
11.6.2 Dentritech Business Overview
11.6.3 Dentritech Artificial Blood Introduction
11.6.4 Dentritech Revenue in Artificial Blood Business (2018-2023)
11.6.5 Dentritech Recent Development
11.7 FluorO2 Therapeutics
11.7.1 FluorO2 Therapeutics Company Detail
11.7.2 FluorO2 Therapeutics Business Overview
11.7.3 FluorO2 Therapeutics Artificial Blood Introduction
11.7.4 FluorO2 Therapeutics Revenue in Artificial Blood Business (2018-2023)
11.7.5 FluorO2 Therapeutics Recent Development
11.8 Nuvox Pharma
11.8.1 Nuvox Pharma Company Detail
11.8.2 Nuvox Pharma Business Overview
11.8.3 Nuvox Pharma Artificial Blood Introduction
11.8.4 Nuvox Pharma Revenue in Artificial Blood Business (2018-2023)
11.8.5 Nuvox Pharma Recent Development
11.9 Alpha Therapeutic Corporation
11.9.1 Alpha Therapeutic Corporation Company Detail
11.9.2 Alpha Therapeutic Corporation Business Overview
11.9.3 Alpha Therapeutic Corporation Artificial Blood Introduction
11.9.4 Alpha Therapeutic Corporation Revenue in Artificial Blood Business (2018-2023)
11.9.5 Alpha Therapeutic Corporation Recent Development
11.10 HemoBioTech
11.10.1 HemoBioTech Company Detail
11.10.2 HemoBioTech Business Overview
11.10.3 HemoBioTech Artificial Blood Introduction
11.10.4 HemoBioTech Revenue in Artificial Blood Business (2018-2023)
11.10.5 HemoBioTech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Artificial Blood Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Human Blood
    Table 3. Key Players of Synthetic Blood
    Table 4. Key Players of Animal Blood
    Table 5. Global Artificial Blood Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Artificial Blood Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Artificial Blood Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Artificial Blood Market Share by Region (2018-2023)
    Table 9. Global Artificial Blood Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Artificial Blood Market Share by Region (2024-2029)
    Table 11. Artificial Blood Market Trends
    Table 12. Artificial Blood Market Drivers
    Table 13. Artificial Blood Market Challenges
    Table 14. Artificial Blood Market Restraints
    Table 15. Global Artificial Blood Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Artificial Blood Market Share by Players (2018-2023)
    Table 17. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2022)
    Table 18. Ranking of Global Top Artificial Blood Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Artificial Blood Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Artificial Blood Product Solution and Service
    Table 22. Date of Enter into Artificial Blood Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Artificial Blood Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Artificial Blood Revenue Market Share by Type (2018-2023)
    Table 26. Global Artificial Blood Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Artificial Blood Revenue Market Share by Type (2024-2029)
    Table 28. Global Artificial Blood Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Artificial Blood Revenue Market Share by Application (2018-2023)
    Table 30. Global Artificial Blood Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Artificial Blood Revenue Market Share by Application (2024-2029)
    Table 32. North America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Artificial Blood Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Artificial Blood Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Artificial Blood Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Artificial Blood Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Artificial Blood Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Artificial Blood Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Artificial Blood Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Artificial Blood Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Artificial Blood Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Artificial Blood Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Artificial Blood Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Artificial Blood Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Artificial Blood Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Artificial Blood Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Dextro-Sang Corporation Company Detail
    Table 48. Dextro-Sang Corporation Business Overview
    Table 49. Dextro-Sang Corporation Artificial Blood Product
    Table 50. Dextro-Sang Corporation Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 51. Dextro-Sang Corporation Recent Development
    Table 52. BioPure Corporation Company Detail
    Table 53. BioPure Corporation Business Overview
    Table 54. BioPure Corporation Artificial Blood Product
    Table 55. BioPure Corporation Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 56. BioPure Corporation Recent Development
    Table 57. Sangart Company Detail
    Table 58. Sangart Business Overview
    Table 59. Sangart Artificial Blood Product
    Table 60. Sangart Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 61. Sangart Recent Development
    Table 62. Northfield Laboratories Company Detail
    Table 63. Northfield Laboratories Business Overview
    Table 64. Northfield Laboratories Artificial Blood Product
    Table 65. Northfield Laboratories Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 66. Northfield Laboratories Recent Development
    Table 67. Baxter International Company Detail
    Table 68. Baxter International Business Overview
    Table 69. Baxter International Artificial Blood Product
    Table 70. Baxter International Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 71. Baxter International Recent Development
    Table 72. Dentritech Company Detail
    Table 73. Dentritech Business Overview
    Table 74. Dentritech Artificial Blood Product
    Table 75. Dentritech Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 76. Dentritech Recent Development
    Table 77. FluorO2 Therapeutics Company Detail
    Table 78. FluorO2 Therapeutics Business Overview
    Table 79. FluorO2 Therapeutics Artificial Blood Product
    Table 80. FluorO2 Therapeutics Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 81. FluorO2 Therapeutics Recent Development
    Table 82. Nuvox Pharma Company Detail
    Table 83. Nuvox Pharma Business Overview
    Table 84. Nuvox Pharma Artificial Blood Product
    Table 85. Nuvox Pharma Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 86. Nuvox Pharma Recent Development
    Table 87. Alpha Therapeutic Corporation Company Detail
    Table 88. Alpha Therapeutic Corporation Business Overview
    Table 89. Alpha Therapeutic Corporation Artificial Blood Product
    Table 90. Alpha Therapeutic Corporation Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 91. Alpha Therapeutic Corporation Recent Development
    Table 92. HemoBioTech Company Detail
    Table 93. HemoBioTech Business Overview
    Table 94. HemoBioTech Artificial Blood Product
    Table 95. HemoBioTech Revenue in Artificial Blood Business (2018-2023) & (US$ Million)
    Table 96. HemoBioTech Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Artificial Blood Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Artificial Blood Market Share by Type: 2022 VS 2029
    Figure 3. Human Blood Features
    Figure 4. Synthetic Blood Features
    Figure 5. Animal Blood Features
    Figure 6. Global Artificial Blood Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Artificial Blood Market Share by Application: 2022 VS 2029
    Figure 8. Hemoglobin-Based Oxygen Carriers (HBOCs) Case Studies
    Figure 9. Perflurocarbon Emulsions (PFCEs) Case Studies
    Figure 10. Artificial Blood Report Years Considered
    Figure 11. Global Artificial Blood Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Artificial Blood Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Artificial Blood Market Share by Region: 2022 VS 2029
    Figure 14. Global Artificial Blood Market Share by Players in 2022
    Figure 15. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Artificial Blood Revenue in 2022
    Figure 17. North America Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Artificial Blood Market Share by Country (2018-2029)
    Figure 19. United States Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Artificial Blood Market Share by Country (2018-2029)
    Figure 23. Germany Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Artificial Blood Market Share by Region (2018-2029)
    Figure 31. China Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Artificial Blood Market Share by Country (2018-2029)
    Figure 39. Mexico Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Artificial Blood Market Share by Country (2018-2029)
    Figure 43. Turkey Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Artificial Blood Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Dextro-Sang Corporation Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 46. BioPure Corporation Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 47. Sangart Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 48. Northfield Laboratories Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 49. Baxter International Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 50. Dentritech Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 51. FluorO2 Therapeutics Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 52. Nuvox Pharma Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 53. Alpha Therapeutic Corporation Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 54. HemoBioTech Revenue Growth Rate in Artificial Blood Business (2018-2023)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS